Company: NCEL
Filing Date: 2025-09-03
Form Type: F-4/A
Source: 0001213900-25-084157
Chunk: 698

Company: NewcelX Ltd.
Filing Date: 2025-09-03
Form: F-4/A
Chunk 698
---
 privilege of any party, except as expressly set forth herein. 3. Entire Agreement. The Agreement, as amended by this Amendment, and the documents or instruments attached hereto or thereto or referenced herein or therein, constitutes the entire agreement between the Parties with respect to the subject matter of the Agreement, and supersedes all prior agreements and understandings, both oral and written, between the Parties with respect to its subject matter. 4. Further Assurances. Each Party to this Amendment agrees to perform any further acts and execute and deliver any documents that may be reasonably necessary to carry out the provisions of this Amendment. 5. Governing Law. Except to the extent that the Applicable Laws of the State of Israel apply in respect of the procedural aspects of the Merger as set forth in Article I of the Agreement, this Amendment shall be governed by, and construed in accordance with, the laws of the State of Delaware, without regard to any rule or principle that might refer the governance or construction of this Amendment to the Laws of another jurisdiction. 6. Counterparts. This Amendment may be executed in separate counterparts, each of such counterparts shall for all purposes be deemed to be original and all such counterparts shall together constitute but one and the same instrument. [ Remainder of Page Left Blank Intentionally; Signature Page Follows Immediately. ] Annex A-81

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed by their respective authorized signatories as of the date first indicated above.

| NLS PHARMACEUTICS LTD.          |     |                         |
| By:                             |     | /s/ Alexander C. Zwyer  |
| Name:                           |     | Alexander C. Zwyer      |
| Title:                          |     | Chief Executive Officer |
| By:                             |     | /s/ Ronald Hafner       |
| Name:                           |     | Ronald Hafner           |
| Title:                          |     | Chairman of the Board   |
| NLS PHARMACEUTICS (ISRAEL) LTD. |     |                         |
| By:                             |     | /s/ Kobi Maimon         |
| Name:                           |     | Kobi Maimon             |
| Title:                          |     | Director                |
| KADIMASTEM LTD.                 |     |                         |
| By:                             |     | /s/ Ronen Twito         |
| Name:                           |     | Ronen